Losartan Potassium
Product Images NDC 71335-1328

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71335-1328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1.jpg (Fig1)

A line chart comparing the percentage of patients with a primary endpoint over study months between Atenolol (dashed line) and Losartan (solid line). The x-axis represents study duration in months from 0 to 66, and the y-axis shows percentage of patients from 0 to 16%. The chart indicates an adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Fig2.jpg (Fig2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months between Atenolol (dashed line) and Losartan (solid line). The x-axis shows study months from 0 to 66, and the y-axis shows the percentage of patients up to 8%. The graph indicates an adjusted risk reduction of 25% with Losartan, with a p-value of 0.001.*

FDA Label Image

Fig3.jpg (Fig3)

A double forest plot comparing Losartan and Atenolol event rates across patient groups for primary composite events and stroke (fatal/non-fatal). The plots show hazard ratios with confidence intervals, detailing event rates by age, gender, race, ISH, diabetes, and history of cardiovascular disease among 9193 patients.*

FDA Label Image

Fig4.jpg (Fig4)

A line graph comparing the percentage of patients with an event over 48 months for Losartan versus a placebo. The graph includes a risk reduction of 16.1% with a p-value of 0.022, showing the event rate increasing over time for both groups, with the Losartan group consistently below the placebo group.*

FDA Label Image

Image 01

Chemical structure of losartan potassium, showing its characteristic biphenyl-tetrazole moiety with chlorine, hydroxyl, nitrogen atoms, and a potassium counterion.*

FDA Label Image

Label Image (Lbl713351328)

Losartan Potassium 100 mg tablet label packaged by Bryant Ranch Prepack in Burbank, CA. The label includes storage instructions (20-25°C), a barcode, and compares this product to Cozaar 100 mg tablets by West-Ward Pharmaceuticals Corp. The package contains 30 tablets with NDC 71335-13281.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.